 | Up a level |
Munster, Pamela, Mita, Monica, Mahipal, Amit, Nemunaitis, John, Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Paz-Ares, Luis, Hidalgo, Manuel, Rathkopf, Dana, Blumenschein, George, Jr., Smith, David C., Eichhorst, Barbara, Cloughesy, Tim, Filvaroff, Ellen H., Li, Shaoyi, Raymon, Heather, de Haan, Hans, Hege, Kristen and Bendell, Johanna C. (2019). First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy. Cancer Manag. Res., 11. S. 10463 - 10477. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1179-1322
Munster, Pamela N., Mahipal, Amit, Nemunaitis, John J., Mita, Monica M., Paz-Ares, Luis G., Massard, Christophe, Mikkelsen, Tom, Cruz, Cristina, Rathkopf, Dana E., Blumenschein, George R., Hidalgo, Manuel, Smith, David C., Eichhorst, Barbara, Cloughesy, Timothy Francis, Garrick, Brett, Trowe, Torsten, Filvaroff, Ellen, Hege, Kristen and Bendell, Johanna C. (2016). Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755